Shopping Cart 0
Cart Subtotal
USD 0

U.S. Direct Anterior Approach (Total Hip Replacement) Market in ACS Market Research Report, by U.S. Total Hip Replacement Market, U.S. Total Hip Replacement by DAA, U.S. Total Hip Replacement Market for DAA by ACS - Global Forecast Till 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 4450

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 6250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Introduction

Direct anterior approach is a type of hip replacement surgery. It is a minimally invasive surgical technique. In this approach, a 3 to 4-inch incision is made on the front of the hip which allows the joint to be replaced by moving muscles aside along their natural tissue planes, without detaching any tendons. The technique is useful for a quick recovery with less pain and normal functioning after hip replacement. The growing prevalence of osteoarthritis, rising geriatric population, rising R&D by key players of the market, and favorable reimbursement policies are expected to drive the market growth. According to the Arthritis Foundation in 2017, about 30.8 million adults residing within the US were reported to suffer from osteoarthritis. However, the high cost of total hip arthroplasty and incidences of product recalls may hamper the growth of the market.

The US direct anterior approach market is expected to reach a market value of USD 23,129.1 million by 2023 from USD 16,838 million in 2017 and is expected to register a CAGR of 5.4% during the forecast period from 2018 to 2023.

The US direct anterior approach market is segmented by a number of procedures and ambulatory surgical centers.

Key Players

Johnson & Johnson Services Inc. (DePuy Synthes), Stryker, Zimmer Biomet, Smith & Nephew, OrthAlign, Inc., Proliance Surgeons, The Hip and Knee Center, Centre for Special Surgery, Bone & Joint Surgery Clinic, and Orthoillinois.

Study Objectives

To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the US direct anterior approach market

To provide insights into factors affecting the market growth

To analyze the US direct anterior approach market based on various tools such as supply chain analysis and Porter's five force analysis

To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries

To provide country-level analysis of the market with respect to current market size and future perspective

To provide country-level analysis of the market for segments by the number of procedures and ambulatory surgical centers

To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the US direct anterior approach market

Target Audience

Potential Investors

Hospitals and Clinics

Government Associations

Pharmaceutical & Biotechnology Industries

Research Institutes

Suppliers and Distributors

Raw Material Suppliers

Key Findings

The US direct anterior approach market is expected to reach USD 23,129.1 million by 2023 at a CAGR of 5.4 % from 2018 to 2023

On the basis of the number of procedures, the market is expected to register a CAGR of 6.1% by 2023

On the basis of ambulatory surgical centers, the market is expected to register a CAGR of 13.6% by 2023

READ MORE

Table Of Content

Scope

Table of Contents:

1 Report Prologue

2 Market Introduction

2.1 Introduction

2.2 Assumptions & Limitations

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Increasing prevalence osteoarthritis

4.2.2 Growing geriatric population

4.2.3 Rising R&D by the key players of the market

4.2.4 Favourable reimbursement policies

4.2.5 Drivers Impact Analysis

4.3 Restraints

4.3.1 High cost of total hip arthroplasty

4.3.2 Incidence of product recalls

4.3.3 Restraints Impact Analysis

4.4 Opportunity

4.4.1 Rising demands for the minimally invasive surgical procedures

4.5 Macroeconomic Indicator

4.6 Product Trends in the U.S Direct Anterior Approach (Total Hip Replacement) Market in ACS

4.7 Trends in the U.S Direct Anterior Approach (Total Hip Replacement) Market in ACS

5 Market Factor Analysis

5.1 Value Chain Analysis

5.1.1 R&D and Designing

5.1.2 Manufacturing

5.1.3 Distribution & Sales

5.1.4 Post-Sales Review

5.2 Porter's Five Forces Model

5.2.1 Bargaining Power of Suppliers

5.2.1 Bargaining Power of Buyers

5.2.2 Threat of New Entrants

5.2.3 Threat of Substitutes

5.2.4 Intensity of Rivalry

5.3 Investment Opportunities

5.4 Pricing Analysis

5.5 Demand & Supply: Gap Analysis

6 U.S Direct Anterior Approach (Total Hip Replacement) Market

6.1 Total Hip Replacement

6.1.1 Total Hip Replacement by DAA (Direct anterior approach)

7 Competitive Landscape

7.1 Competitive Landscape

7.1.1 Ambulatory Surgical Centers

7.1.1.1 Introduction

7.1.2 Product Mapping

8 Company Profile

8.1 Johnson & Johnson Services Inc. (DePuy Synthes)

8.1.1 Company Overview

8.1.2 Financial Overview

8.1.3 Products Offering

8.1.4 Key Developments

8.1.5 SWOT Analysis

8.1.6 Key Strategy

8.2 Stryker

8.2.1 Company Overview

8.2.2 Financial Overview

8.2.3 Products Offering

8.2.4 Key Developments

8.2.5 SWOT Analysis

8.2.6 Key Strategy

8.3 Zimmer Biomet

8.3.1 Company Overview

8.3.2 Financial Overview

8.3.3 Products Offering

8.3.4 Key Developments

8.3.5 SWOT Analysis

8.3.6 Key Strategy

8.4 Smith & Nephew

8.4.1 Company Overview

8.4.2 Financial Overview

8.4.3 Products Offering

8.4.4 Key Developments

8.4.5 SWOT Analysis

8.4.6 Key Strategy

8.5 OrthAlign, Inc.

8.5.1 Company Overview

8.5.2 Financial Overview

8.5.3 Products Offering

8.5.4 Key Developments

8.5.5 SWOT Analysis

8.5.6 Key Strategy

8.6 Proliance Surgeons

8.6.1 Company Overview

8.6.2 Financial Overview

8.6.3 Products Offering

8.6.4 Key Developments

8.6.5 SWOT Analysis

8.6.6 Key Strategy

8.7 The Hip and knee center

8.7.1 Company Overview

8.7.2 Financial Overview

8.7.3 Products Offering

8.7.4 Key Developments

8.7.5 SWOT Analysis

8.7.6 Key Strategy

8.8 Centre for Special Surgery

8.8.1 Company Overview

8.8.2 Financial Overview

8.8.3 Products Offering

8.8.4 Key Developments

8.8.5 SWOT Analysis

8.8.6 Key Strategy

8.9 Bone & Joint Surgery Clinic

8.9.1 Company Overview

8.9.2 Financial Overview

8.9.3 Products Offering

8.9.4 Key Developments

8.9.5 SWOT Analysis

8.9.6 Key Strategy

8.1 Orthoillinois

8.10.1 Company Overview

8.10.2 Financial Overview

8.10.3 Products Offering

8.10.4 Key Developments

8.10.5 SWOT Analysis

8.10.6 Key Strategy

9 Conclusion

9.1 Key Findings

9.1.1 From CEO's View Point

9.2 Key Companies and Surgical Ambulatory Centers to Watch


List Of Figure

List of Figures:

FIGURE 1 RESEARCH PROCESS

FIGURE 2 DROC ANALYSIS OF THE U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET IN ASC

FIGURE 3 DRIVERS IMPACT ANALYSIS: U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET

FIGURE 4 RESTRAINTS IMPACT ANALYSIS: U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET

FIGURE 5 VALUE CHAIN: U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET

FIGURE 6 PORTER'S FIVE FORCES MODEL: THE U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET IN ASC

FIGURE 7 U.S. TOTAL HIP REPLACEMENT MARKET 2015-2023 (USD MILLION)

FIGURE 8 U.S. TOTAL HIP REPLACEMENT BY DAA (DIRECT ANTERIOR APPROACH) 2015-2023 (USD MILLION)

FIGURE 9 U.S. TOTAL HIP REPLACEMENT MARKET FOR DAA BY AMBULATORY SURGICAL CENTERS 2015-2023 (USD MILLION)

FIGURE 10 U.S. TOTAL HIP REPLACEMENT, MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2017 (%)


List Of Table

List of Tables:

TABLE 1 U.S. TOTAL HIP REPLACEMENT MARKET 2015-2023 (USD MILLION)

TABLE 2 U.S. TOTAL HIP REPLACEMENT MARKET, BY NUMBER OF PROCEDURE 2012-2015

TABLE 3 U.S. TOTAL HIP REPLACEMENT BY DAA (DIRECT ANTERIOR APPROACH) 2015-2023 (USD MILLION)

TABLE 4 U.S. TOTAL HIP REPLACEMENT BY DAA, NUMBER OF PROCEDURE 2014-2017 (USD MILLION)

TABLE 5 U.S. TOTAL HIP REPLACEMENT MARKET FOR DAA BY AMBULATORY SURGICAL CENTERS ASC 2015-2023 (USD MILLION)

TABLE 6 TOP 3 U.S. AMBULATORY SURGICAL CENTER FOR THR (2016)

Licence Rights

"Single User License: OnIine PDF View Only
Enterprise-user License : Print & download option is available."

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Johnson & Johnson Services Inc. (DePuy Synthes), Stryker, Zimmer Biomet, Smith & Nephew, OrthAlign, Inc., Proliance Surgeons, The Hip and Knee Center, Centre for Special Surgery, Bone & Joint Surgery Clinic and Orthoillinois

Introduction

Direct anterior approach is a type of hip replacement surgery. It is a minimally invasive surgical technique. In this approach, a 3 to 4-inch incision is made on the front of the hip which allows the joint to be replaced by moving muscles aside along their natural tissue planes, without detaching any tendons. The technique is useful for a quick recovery with less pain and normal functioning after hip replacement. The growing prevalence of osteoarthritis, rising geriatric population, rising R&D by key players of the market, and favorable reimbursement policies are expected to drive the market growth. According to the Arthritis Foundation in 2017, about 30.8 million adults residing within the US were reported to suffer from osteoarthritis. However, the high cost of total hip arthroplasty and incidences of product recalls may hamper the growth of the market.

The US direct anterior approach market is expected to reach a market value of USD 23,129.1 million by 2023 from USD 16,838 million in 2017 and is expected to register a CAGR of 5.4% during the forecast period from 2018 to 2023.

The US direct anterior approach market is segmented by a number of procedures and ambulatory surgical centers.

Key Players

Johnson & Johnson Services Inc. (DePuy Synthes), Stryker, Zimmer Biomet, Smith & Nephew, OrthAlign, Inc., Proliance Surgeons, The Hip and Knee Center, Centre for Special Surgery, Bone & Joint Surgery Clinic, and Orthoillinois.

Study Objectives

To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the US direct anterior approach market

To provide insights into factors affecting the market growth

To analyze the US direct anterior approach market based on various tools such as supply chain analysis and Porter's five force analysis

To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries

To provide country-level analysis of the market with respect to current market size and future perspective

To provide country-level analysis of the market for segments by the number of procedures and ambulatory surgical centers

To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the US direct anterior approach market

Target Audience

Potential Investors

Hospitals and Clinics

Government Associations

Pharmaceutical & Biotechnology Industries

Research Institutes

Suppliers and Distributors

Raw Material Suppliers

Key Findings

The US direct anterior approach market is expected to reach USD 23,129.1 million by 2023 at a CAGR of 5.4 % from 2018 to 2023

On the basis of the number of procedures, the market is expected to register a CAGR of 6.1% by 2023

On the basis of ambulatory surgical centers, the market is expected to register a CAGR of 13.6% by 2023

READ MORE

Scope

Table of Contents:

1 Report Prologue

2 Market Introduction

2.1 Introduction

2.2 Assumptions & Limitations

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.2.1 Increasing prevalence osteoarthritis

4.2.2 Growing geriatric population

4.2.3 Rising R&D by the key players of the market

4.2.4 Favourable reimbursement policies

4.2.5 Drivers Impact Analysis

4.3 Restraints

4.3.1 High cost of total hip arthroplasty

4.3.2 Incidence of product recalls

4.3.3 Restraints Impact Analysis

4.4 Opportunity

4.4.1 Rising demands for the minimally invasive surgical procedures

4.5 Macroeconomic Indicator

4.6 Product Trends in the U.S Direct Anterior Approach (Total Hip Replacement) Market in ACS

4.7 Trends in the U.S Direct Anterior Approach (Total Hip Replacement) Market in ACS

5 Market Factor Analysis

5.1 Value Chain Analysis

5.1.1 R&D and Designing

5.1.2 Manufacturing

5.1.3 Distribution & Sales

5.1.4 Post-Sales Review

5.2 Porter's Five Forces Model

5.2.1 Bargaining Power of Suppliers

5.2.1 Bargaining Power of Buyers

5.2.2 Threat of New Entrants

5.2.3 Threat of Substitutes

5.2.4 Intensity of Rivalry

5.3 Investment Opportunities

5.4 Pricing Analysis

5.5 Demand & Supply: Gap Analysis

6 U.S Direct Anterior Approach (Total Hip Replacement) Market

6.1 Total Hip Replacement

6.1.1 Total Hip Replacement by DAA (Direct anterior approach)

7 Competitive Landscape

7.1 Competitive Landscape

7.1.1 Ambulatory Surgical Centers

7.1.1.1 Introduction

7.1.2 Product Mapping

8 Company Profile

8.1 Johnson & Johnson Services Inc. (DePuy Synthes)

8.1.1 Company Overview

8.1.2 Financial Overview

8.1.3 Products Offering

8.1.4 Key Developments

8.1.5 SWOT Analysis

8.1.6 Key Strategy

8.2 Stryker

8.2.1 Company Overview

8.2.2 Financial Overview

8.2.3 Products Offering

8.2.4 Key Developments

8.2.5 SWOT Analysis

8.2.6 Key Strategy

8.3 Zimmer Biomet

8.3.1 Company Overview

8.3.2 Financial Overview

8.3.3 Products Offering

8.3.4 Key Developments

8.3.5 SWOT Analysis

8.3.6 Key Strategy

8.4 Smith & Nephew

8.4.1 Company Overview

8.4.2 Financial Overview

8.4.3 Products Offering

8.4.4 Key Developments

8.4.5 SWOT Analysis

8.4.6 Key Strategy

8.5 OrthAlign, Inc.

8.5.1 Company Overview

8.5.2 Financial Overview

8.5.3 Products Offering

8.5.4 Key Developments

8.5.5 SWOT Analysis

8.5.6 Key Strategy

8.6 Proliance Surgeons

8.6.1 Company Overview

8.6.2 Financial Overview

8.6.3 Products Offering

8.6.4 Key Developments

8.6.5 SWOT Analysis

8.6.6 Key Strategy

8.7 The Hip and knee center

8.7.1 Company Overview

8.7.2 Financial Overview

8.7.3 Products Offering

8.7.4 Key Developments

8.7.5 SWOT Analysis

8.7.6 Key Strategy

8.8 Centre for Special Surgery

8.8.1 Company Overview

8.8.2 Financial Overview

8.8.3 Products Offering

8.8.4 Key Developments

8.8.5 SWOT Analysis

8.8.6 Key Strategy

8.9 Bone & Joint Surgery Clinic

8.9.1 Company Overview

8.9.2 Financial Overview

8.9.3 Products Offering

8.9.4 Key Developments

8.9.5 SWOT Analysis

8.9.6 Key Strategy

8.1 Orthoillinois

8.10.1 Company Overview

8.10.2 Financial Overview

8.10.3 Products Offering

8.10.4 Key Developments

8.10.5 SWOT Analysis

8.10.6 Key Strategy

9 Conclusion

9.1 Key Findings

9.1.1 From CEO's View Point

9.2 Key Companies and Surgical Ambulatory Centers to Watch


List Of Figure

List of Figures:

FIGURE 1 RESEARCH PROCESS

FIGURE 2 DROC ANALYSIS OF THE U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET IN ASC

FIGURE 3 DRIVERS IMPACT ANALYSIS: U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET

FIGURE 4 RESTRAINTS IMPACT ANALYSIS: U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET

FIGURE 5 VALUE CHAIN: U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET

FIGURE 6 PORTER'S FIVE FORCES MODEL: THE U.S. DIRECT ANTERIOR APPROACH (TOTAL HIP REPLACEMENT) MARKET IN ASC

FIGURE 7 U.S. TOTAL HIP REPLACEMENT MARKET 2015-2023 (USD MILLION)

FIGURE 8 U.S. TOTAL HIP REPLACEMENT BY DAA (DIRECT ANTERIOR APPROACH) 2015-2023 (USD MILLION)

FIGURE 9 U.S. TOTAL HIP REPLACEMENT MARKET FOR DAA BY AMBULATORY SURGICAL CENTERS 2015-2023 (USD MILLION)

FIGURE 10 U.S. TOTAL HIP REPLACEMENT, MARKET SHARE ANALYSIS BY MAJOR PLAYERS, 2017 (%)


List Of Table

List of Tables:

TABLE 1 U.S. TOTAL HIP REPLACEMENT MARKET 2015-2023 (USD MILLION)

TABLE 2 U.S. TOTAL HIP REPLACEMENT MARKET, BY NUMBER OF PROCEDURE 2012-2015

TABLE 3 U.S. TOTAL HIP REPLACEMENT BY DAA (DIRECT ANTERIOR APPROACH) 2015-2023 (USD MILLION)

TABLE 4 U.S. TOTAL HIP REPLACEMENT BY DAA, NUMBER OF PROCEDURE 2014-2017 (USD MILLION)

TABLE 5 U.S. TOTAL HIP REPLACEMENT MARKET FOR DAA BY AMBULATORY SURGICAL CENTERS ASC 2015-2023 (USD MILLION)

TABLE 6 TOP 3 U.S. AMBULATORY SURGICAL CENTER FOR THR (2016)

"Single User License: OnIine PDF View Only
Enterprise-user License : Print & download option is available."

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Johnson & Johnson Services Inc. (DePuy Synthes), Stryker, Zimmer Biomet, Smith & Nephew, OrthAlign, Inc., Proliance Surgeons, The Hip and Knee Center, Centre for Special Surgery, Bone & Joint Surgery Clinic and Orthoillinois